// App-Quantinova.ai

: Preliminary Outcomes of Orelabrutinib Plus RCHOP in Treatment-Naïve Patients with Double-Expression Diffuse Large B Cell Lymphoma

Researchers

Presenter

  • Yang Yang

Principal Investigators

  • Jingsong He

  • Yi Zhao

  • Wenjun Wu

  • Gaofeng Zheng

  • Xiaoyan Han

  • Donghua He

  • He Huang

  • Zhen Cai

Medical Centers

  • Institute of Hematology, Zhejiang University, Hangzhou, China

  • Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

  • Liangzhu Laboratory, Zhejiang University Medical Center, West Wenyi Road, Hangzhou , China, Hangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

Biomarkers

  • B-cell lymphoma 2

  • cMYC

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Vincristine

  • Doxorubicin

  • Prednisone

  • Rituximab

Outcome

  • N/A

Study Design

  • Single Arm

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved